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Introduction 1 
With cardiovascular disease (CVD) recognised as a leading cause of morbidity and mortality 2 
in the UK, the contribution of major modifiable risk factors, such as diet, are becoming 3 
increasingly more important in CVD prevention. A high saturated fatty acid (SFA) intake is 4 
associated with an increased risk of coronary heart disease (CHD) and for this reason key 5 
public health advice recommends that SFA should contribute less than 10% of total energy 6 
(TE) [1] . However UK adults are currently exceeding this recommendation, with SFA intake 7 
accounting for 12% of TE [2]. Therefore, there is a need for novel interventions to help 8 
reduce or replace the amount of SFA in the diet. In comparison to substitution with 9 
carbohydrates, evidence suggests that replacement of SFAs with unsaturated fatty acids 10 
(FA) may provide a greater CVD risk reduction [3]. Indeed, lowering intake of SFA, through 11 
modification of FA profile of the diet, as opposed to reduction in its total fat content, may 12 
reduce cardiovascular events by up to 14% [3], which could have a major impact on public 13 
health.  14 
This article will present the current prospective evidence on milk and milk-derived 15 
foods in relation to CVD events. The potential of ruminant feeding-based public health 16 
strategies aimed at reducing cardiovascular risk markers, through replacement of SFA in 17 
milk fat with unsaturated FAs, will also be discussed.  18 
Nutrient composition of milk and dairy foods  19 
Ruminant milk is nutrient dense and is a key source of energy, protein and micronutrients 20 
such as calcium, phosphorus, potassium, iodine and vitamin D [4, 5]. Consequently, 21 
reducing dairy consumption, as a means of lowering SFA intake, could lead to inadequate 22 
intake of these nutrients, especially in vulnerable infant and elderly populations.  23 
Additionally, other nutrients found in the diary matrix may be cardio-protective. 24 
Calcium and milk proteins (whey and casein) are linked to the blood pressure regulatory 25 
properties of dairy; it is believed that protein-derived bioactive peptides have a role to play 26 
in the anti-hypertensive aspects of dairy, in part, through inhibition of the angiotensin-I-27 
converting enzyme mechanism [5]. When compared with the intake of their industrially 28 
produced counterparts, ruminant trans fatty acids (rTFA) do not appear to have the negative 29 
effects on CVD risk, with some studies inferring that their intake may be associated with 30 
reduced cardiovascular risk [4, 5]. It is recognised that rTFA are consumed at very small 31 
quantities but research is needed to clarify whether increasing rTFA intake, through 32 
manipulation of the fatty acid profile of dairy products, affects cardio-metabolic health. 33 
While there are some limited data which suggest that the consumption of milk-derived 34 
conjugated linoleic acid (CLA) may be associated with beneficial cardio-protective effects, 35 
more conclusive evidence is needed to fully understand the impact of CLA on CVD risk 36 
outcomes [6]. 37 
Contribution of milk to saturated fat intake  38 
Milk and dairy products (excluding butter and composite dairy dishes) contribute to almost 39 
one quarter of SFA intake the UK diet [7] . A large portion of energy in milk is derived from 40 
fat, with SFA accounting for approximately 70% of total milk fat, predominantly in the form 41 
of myristic (C14:0), palmitic (C16:0) and stearic (C18:0) acids. As a result of their major 42 
contribution to SFA intake, it has been perceived that the consumption of milk and milk-43 
derived products should be limited as a means of reducing the risk of CVD. However, there 44 
is good evidence of the contrary, as will be explored further in this article.  45 
Milk and cholesterol levels  46 
While it is recognised that the effect of SFA on CVD is linked to increases in serum lipids, 47 
predominantly LDL-cholesterol (LDL-C), some intervention studies have revealed that milk or 48 
dairy fat feeding does not significantly increase this risk marker for CVD and cross-sectional 49 
evidence suggests that FAs associated with dairy fat intake may have a beneficial effect on 50 
LDL-C particle size distribution; however these findings require further investigation (see 51 
[5]). Furthermore, it is recognised that there is a differential effect of dairy product type on 52 
CVD risk factors, such that fermented dairy products may have a more favourable effect on 53 
blood lipid profiles than intake of butter, matched for fat and SFA content [8]. Although 54 
limited data are available, it is hypothesised that the higher calcium content of the cheese 55 
may lead to a reduced fat absorption when compared to butter, probably through the 56 
intestinal formation of insoluble FA calcium soaps [8]. 57 
Prospective evidence on milk/dairy foods and cardiovascular disease  58 
There have been a number of overviews published on the relationship between consumption 59 
of milk and dairy foods and CVD. To date, the largest was a meta-analysis based on 38 60 
cohort studies [9]. This meta-analysis with the addition of data from six recently published 61 
studies  (see [10] for details) showed that the overall relative risk (RR) for CHD was 0.92, 62 
suggesting a reduction of about 8% in those subjects who reported the highest milk/dairy 63 
intake, compared with subjects with the lowest intake (17 studies RR: 0.92; 95% CI, 0.86–64 
0.99). This meta-analysis also showed that a higher milk/dairy intake was related to a 19% 65 
lower risk of stroke (12 studies RR: 0.81; 95% CI, 0.71–0.92). Five studies reported on risk 66 
of haemorrhagic strokes (RR: 0.75; 95% CI, 0.60-0.94) and three studies on subarachnoid 67 
bleeds (RR 0.93; 95% CI, 0.84-1.02) and these studies suggested a 25% and 7% reduction 68 
in risk with the highest milk/dairy intake for haemorrhagic strokes and subarachnoid bleeds, 69 
respectively [10].  70 
In line with the aforementioned, meta-analysis evidence from prospective cohort 71 
studies show no association between individual dairy foods and CHD risk [11-15], except for 72 
an inverse association between cheese consumption and risk of myocardial infarction [16], 73 
and between low-fat milk and incident CHD [17]. In relation to stroke, the findings were 74 
inconsistent, with several studies showing a significant inverse association with low-fat milk 75 
[17], low-fat dairy [18] and fermented dairy products  [17, 19], whereas in four other 76 
studies the consumption of specific dairy foods was not related to stroke [12, 13, 15, 20].  77 
Overall, the evidence from prospective cohort studies shows that milk/dairy 78 
consumption does not increase CVD risk. Conversely, individuals with the highest milk/dairy 79 
intake had the lowest risk of CVD. However, the effects of individual dairy foods such as 80 
butter and cheese, as well as benefits of fat-reduced milk and SFA-reduced milk are less 81 
certain.     82 
Modification of the fatty acid profile of ruminant milk 83 
Although some argue that the nutrients within the dairy food matrix may act synergistically 84 
with SFA to prevent the onset of CVD, the potential additional cardio-protective benefits of 85 
replacing milk SFA with cis-MUFA or cis-PUFA, through dietary supplementation of the 86 
bovine diet with oil seeds or plant oils (typically rich in C18 MUFA and/or PUFA), needs to be 87 
further explored [4, 5]. Supplementation of the diet with oils that are rich in long chain 88 
unsaturated FA reduces the mammary gland synthesis of short- and medium chain SFA 89 
(C6:0-C16:0) and subsequently increases long-chain FA profile of the milk [4, 5]. 90 
Additionally, this strategy has the added benefit of removing SFA from the food chain, whilst 91 
maintaining the valuable contribution that milk makes to macro- and micronutrient intake. 92 
Modified saturated fat-reduced dairy consumption and cardiovascular disease 93 
risk 94 
There is a scarcity of randomised controlled trial data that has examined the impact of 95 
consuming saturated fat-reduced, unsaturated fat-rich modified milk and dairy products on 96 
CVD risk. Although the limited research suggests that intake of modified dairy products may 97 
favourably impact on CVD risk markers, an inherent limitation of these studies was a 98 
reliance on fasting circulating lipid levels as a biomarker for CVD risk (for detailed review, 99 
see [5]). Given the aforementioned complexity of the structural properties of milk, and 100 
considering that humans spend the majority of their time in the postprandial state, future 101 
research needs to provide a more meaningful holistic evaluation and examine the impact of 102 
modified dairy consumption on a variety of risk factors linked to the pathophysiology of CVD 103 
including endothelial function, arterial stiffness, postprandial lipaemia and inflammatory 104 
biomarkers [4]. 105 
The University of Reading is contributing to this fundamental research gap by 106 
conducting a UK Medical Research Council-funded project called the RESET (REplacement of 107 
SaturatEd fat in dairy on Total cholesterol) study; it is testing the hypothesis that modified 108 
dairy products (milk, cheese and butter), which have a substantial proportion of SFA 109 
replaced with cis-MUFA, will improve vascular function, reduce inflammatory markers and 110 
other risk markers for CVD relative to matched commercially available products in both 111 
chronic and acute within chronic settings (ClinicalTrials.gov NCT02089035). Findings from 112 
the RESET intervention study (anticipated to be completed in December 2015), will help to 113 
elucidate if reducing the SFA content of dairy products is beneficial to numerous 114 
components of cardiovascular health and may have potential for improving the overall 115 
health of the population. 116 
Conclusion 117 
Milk and milk-derived products are complex, nutrient dense foods but there is some concern 118 
that their intake could increase risk of CVD. Despite the significant SFA profile of milk fat, 119 
epidemiological evidence and experimental data challenge this perception. Indeed, these 120 
data suggest that milk may afford some protection from cardiovascular events, but the 121 
evidence is less substantial for other dairy products. There is a need to carry out well-122 
designed, human dietary intervention studies to determine whether consumption of modified 123 
milk and dairy products, with an unsaturated FA enhanced profile, may provide more 124 
protection from CVD in both healthy and at-risk populations.   125 
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